Tags

Type your tag names separated by a space and hit enter

Atypical neuroleptics: compulsive disorders.
Prescrire Int. 2014 Feb; 23(146):43-4.PI

Abstract

Compulsive disorders are known adverse effects of dopamine agonists. Atypical neuroleptics (amisulpride, aripiprazole, olanzapine, paliperidone, quetiapine and risperidone) have also been implicated in cases of pathological gambling, hypersexuality, and compulsive eating and shopping, with sometimes serious social and familial consequences. The compulsive disorders improved or ceased when the neuroleptic was withdrawn or replaced. Patients must be informed of these possible adverse effects and monitored for behavioural changes. If such disorders occur, they can be managed by withdrawing the drug, reducing the dosage, or switching to another neuroleptic.

Pub Type(s)

Journal Article

Language

eng

PubMed ID

24669386

Citation

"Atypical Neuroleptics: Compulsive Disorders." Prescrire International, vol. 23, no. 146, 2014, pp. 43-4.
Atypical neuroleptics: compulsive disorders. Prescrire Int. 2014;23(146):43-4.
(2014). Atypical neuroleptics: compulsive disorders. Prescrire International, 23(146), 43-4.
Atypical Neuroleptics: Compulsive Disorders. Prescrire Int. 2014;23(146):43-4. PubMed PMID: 24669386.
* Article titles in AMA citation format should be in sentence-case
TY - JOUR T1 - Atypical neuroleptics: compulsive disorders. PY - 2014/3/27/entrez PY - 2014/3/29/pubmed PY - 2014/6/6/medline SP - 43 EP - 4 JF - Prescrire international JO - Prescrire Int VL - 23 IS - 146 N2 - Compulsive disorders are known adverse effects of dopamine agonists. Atypical neuroleptics (amisulpride, aripiprazole, olanzapine, paliperidone, quetiapine and risperidone) have also been implicated in cases of pathological gambling, hypersexuality, and compulsive eating and shopping, with sometimes serious social and familial consequences. The compulsive disorders improved or ceased when the neuroleptic was withdrawn or replaced. Patients must be informed of these possible adverse effects and monitored for behavioural changes. If such disorders occur, they can be managed by withdrawing the drug, reducing the dosage, or switching to another neuroleptic. SN - 1167-7422 UR - https://www.unboundmedicine.com/medline/citation/24669386/Atypical_neuroleptics:_compulsive_disorders_ DB - PRIME DP - Unbound Medicine ER -
Try the Free App:
Prime PubMed app for iOS iPhone iPad
Prime PubMed app for Android
Prime PubMed is provided
free to individuals by:
Unbound Medicine.